Japan Lifeline Co (Japan Lifeline Co) ROCE % : 20.73% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Japan Lifeline Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Japan Lifeline Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 20.73%.

Japan Lifeline Co ROCE % Historical Data

The historical data trend for Japan Lifeline Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Lifeline Co ROCE % Chart

Japan Lifeline Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

19.13

8.15

16.78

15.50

16.71

Japan Lifeline Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															21.03	21.18	16.10	20.73	13.27

Japan Lifeline Co ROCE % Calculation

Japan Lifeline Co's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	70.759	/	( ( (558.421 - 107.59)	+	(490.653 - 94.614) )	/ 2 )
	=	70.759	/	( (450.831	+	396.039)	/ 2 )
	=	70.759	/	423.435
	=	16.71 %

Japan Lifeline Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	82.372	/	( ( (470.425 - 83.053)	+	(487.653 - 80.385) )	/ 2 )
	=	82.372	/	( ( 387.372	+	407.268 )	/ 2 )
	=	82.372	/	397.32
	=	20.73 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Japan Lifeline Co (OTCPK:JLFNF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Japan Lifeline Co ROCE % Related Terms

Thank you for viewing the detailed overview of Japan Lifeline Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Japan Lifeline Co (Japan Lifeline Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Japan Lifeline Co Ltd (OTCPK:JLFNF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

7575:Japan

Address

2-2-20, Higashishinagawa, Tennoz Ocean Square, 25th Floor, Shinagawa-ku, Tokyo, JPN, 140-0002

Website

http://www.jll.co.jp

Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.

Japan Lifeline Co (Japan Lifeline Co) Headlines

From GuruFocus

CardioFocus® Announces Full Commercial Launch of HeartLight® System in Japan

By PRNewswire PRNewswire • 07-11-2018